|
GABARAPL2 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 8.153300E-04 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.186300E-04 |
| Normal-vs-Stage2 |
6.742900E-03 |
| Normal-vs-Stage3 |
5.506000E-01 |
| Normal-vs-Stage4 |
8.976300E-03 |
| Stage1-vs-Stage2 |
5.932000E-01 |
| Stage1-vs-Stage3 |
7.848000E-02 |
| Stage1-vs-Stage4 |
6.559000E-01 |
| Stage2-vs-Stage3 |
1.701780E-01 |
| Stage2-vs-Stage4 |
4.375800E-01 |
| Stage3-vs-Stage4 |
1.815370E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.323090E-03 |
| Normal-vs-AfricanAmerican |
8.0285999999985E-05 |
| Normal-vs-Asian |
5.975000E-01 |
| Caucasian-vs-AfricanAmerican |
2.814400E-01 |
| Caucasian-vs-Asian |
2.568400E-01 |
| AfricanAmerican-vs-Asian |
2.072000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.787300E-04 |
| Normal-vs-Female |
2.276200E-02 |
| Male-vs-Female |
2.055600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.419020E-04 |
| Normal-vs-Extreme_Weight |
6.082100E-03 |
| Normal-vs-Obese |
2.981800E-03 |
| Normal-vs-Extreme_Obese |
3.108200E-02 |
| Normal_Weight-vs-Extreme_Weight |
2.041400E-01 |
| Normal_Weight-vs-Obese |
1.669000E-01 |
| Normal_Weight-vs-Extreme_Obese |
7.111000E-01 |
| Extreme_Weight-vs-Obese |
9.715200E-01 |
| Extreme_Weight-vs-Extreme_Obese |
7.278800E-01 |
| Obese-vs-Extreme_Obese |
6.787800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.560000E-01 |
| Normal-vs-Age(41-60Yrs) |
7.080300E-03 |
| Normal-vs-Age(61-80Yrs) |
1.773410E-04 |
| Normal-vs-Age(81-100Yrs) |
1.503510E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.233600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.773600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.219200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.152200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.722200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.527200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
8.570700E-04 |
| Normal-VS-Type2 PRCC |
6.498300E-03 |
| Normal-VS-KIRP CIMP |
1.731740E-02 |
| Normal-VS-Unclassified PRCC |
2.244000E-03 |
| Type1 PRCC-VS-Type2 PRCC |
9.045800E-01 |
| Type1 PRCC-VS-KIRP CIMP |
6.438600E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
7.519400E-01 |
| Type2 PRCC-VS-KIRP CIMP |
6.876800E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
7.158400E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
7.730800E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.414180E-02 |
| Normal-vs-N1 |
1.548150E-02 |
| Normal-vs-N2 |
6.375900E-03 |
| N0-vs-N1 |
8.839000E-01 |
| N0-vs-N2 |
2.693400E-01 |
| N1-vs-N2 |
2.153600E-01 |
|
|
